Trial Details
Not RecruitingBasic Information
| Clinical ID | c2656 |
|---|---|
| Identifier | NL-OMON48827 |
| Trial Title | Exploring the role of faecal mesalazine (5-ASA) concentrations in therapeutic drug monitoring in ulcerative colitis: a pilot study. - TDM-5-ASA |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | 'inflammatory bowel disease' 'ulcerative colitis';10017969;'inflammatory bowel disease';'ulcerative colitis' |
| Interventions | ;Colitis;Mesalazine;Therapeutic drug monitoring;Ulcerative |
Participant Information
| Sponsor | Maag, darm, leverziekten |
|---|---|
| City | - |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | Observational invasive |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |